Trial Profile
Efficacy of tocilizumab in patients with rheumatoid arthritis: Longitudinal German biologics register RABBIT
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Oct 2018
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Therapeutic Use
- 08 Feb 2016 New trial record